Similar trends were also observed in large samples of lung adenocarcinoma (LUAD), skin cutaneous melanoma (SKCM), thyroid carcinoma (THCA), ovarian serous cystadenocarcinoma (OV) and uterine carcinosarcoma (UCS) tissues, as revealed by scatter diagrams (Fig. 1B), likely indicating a reverse relationship between MYSM1 and tumors. This evidence concerns the gene MYSM1 and cutaneous melanoma.